Back to search

Article

Myo-inositol versus Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Anthropometric, Endocrine, Metabolic, and Reproductive Outcomes

2026-01-10

Abstract excerpt

Abstract <h4>Background: </h4> Polycystic ovary syndrome (PCOS) features metabolic and hyperandrogenic abnormalities. Myo-inositol and metformin are insulin-sensitizers with unclear comparative effectiveness. <h4>Objectives: </h4> : To compare the anthropometric, endocrine, metabolic, and reproductive effects of myo-inositol and metformin in women with PCOS. Search Strategy : PubMed, Google Scholar, and Cochrane...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f400e8db-57f3-5198-906a-e3353c857848
DOI
10.22541/au.176801052.29174388/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Myo-inositol versus Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Anthropometric, Endocrine, Metabolic, and Reproductive OutcomesDOI 10.22541/au.176801052.29174388/v1
Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial.Semantic proximity
Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Semantic proximity
Tailoring treatment for PCOS phenotypes.Semantic proximity
Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro FertilizationSemantic proximity
Current and emerging drug treatment strategies for polycystic ovary syndrome.Semantic proximity
MYPP trial: Myo-inositol supplementation to prevent pregnancy complications in women with polycystic ovary syndrome, study protocol for a multicenter, double-blind, randomized controlled trialSemantic proximity
The Impact of Body Mass Index on Metabolic and Pregnancy Outcomes in Patients with Polycystic Ovary SyndromeSemantic proximity
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.Semantic proximity
Clinical guidelines «Polycystic Ovary Syndrome»Semantic proximity
Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetesSemantic proximity
Lipid variations in different polycystic ovary syndrome phenotypes: A systematic review & meta-analysis.Semantic proximity
A bibliometric analysis of the effects of sex hormone profiles in women with polycystic ovary syndromeSemantic proximity
Select a neighboring publication to make it the new centre.